Ireland’s decision to prohibit the sale of nicotine pouches and other non-tobacco nicotine products to individuals under the age of 18 represents a proportionate and overdue step to protect children. Few would dispute the legitimacy of this measure. Preventing youth access to nicotine products is a core public-health objective and is consistent with both harm-reduction…
GINN is a business association representing small and medium-sized enterprises (SMEs) in the EU that are part of the safer nicotine products value chain. We comply fully with all EU transparency rules and requirements, and we have no connections—financial, material, or membership—to the multinational tobacco companies identified in recent reports. A new publication from STOP…
The STOP/Contre‑Feu narrative and the Tobacco Tactics profile both emphasise that some on the GINN Leadership Team previously worked for or with multinational tobacco companies and then infer a present‑day link or alignment with those firms’ lobbying objectives. That move is a textbook guilt‑by‑association tactic: past disclosed employment or sector experience is presented as sufficient to…
In 2023, Canada approved a tobacco-free oral nicotine pouch, marketed under the name Zonnic, as a nicotine replacement therapy for adult smokers. However, the regulatory framework governing its sale and distribution has created an unexpected contradiction: in some circumstances, it is now more difficult for adult smokers to obtain these potentially lower-risk products than to…
This submission is provided on behalf of the Global Institute for Novel Nicotine (GINN), which advocates for proportionate, science-based regulation that recognises tobacco harm reduction (THR) as a legitimate public health strategy Our focus is on the necessary regulation of nicotine products, specifically nicotine pouches, which are currently available on the UK market but operate…
Public understanding of nicotine products increasingly depends on how science is communicated through mainstream media. Yet, misinformation and oversimplified reporting continue to influence how adults who smoke, regulators, and health professionals interpret the risks of non-combustible nicotine products. These narratives often emerge not from a lack of scientific evidence, but from how research is framed,…